Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Since IBA first started to develop proton therapy solutions, we have focused on collaboration and sharing of information. This culture of cooperation has allowed us to work together with clinical partners to help make proton therapy available to anyone who needs it. Our purpose is to offer more cancer patients effective treatments, decreased side effects, leading to a better quality of life. The amount of clinical data on proton therapy is increasing rapidly, making it a challenge to keep up with new findings and advancements. We decided to take advantage of our day-to-day involvement with experienced clinical teams from proton therapy centres worldwide and gather and share information on the use of proton therapy in oncology.
In this booklet, we’ve compiled a list of key scientific publications sorted by indications. We have undertaken this information-gathering exercise with honesty and the highest level of integrity. While utmost care has been taken to ensure that the information contained in this publication is accurate, complete and unbiased, the reader should be aware that articles have been selected and data interpreted. We encourage you to interpret these data carefully and exercise your own critical and scientific judgment. The IBA team believes in the benefits of proton therapy for patients and society. This information will help you and your teams learn more about the extraordinary promise of proton therapy, and we hope you will join us in making it accessible to more patients. We hope that you will find this selection of bibliography informative and helpful.
IBA White Paper
*Please refer to the Terms and Conditions of this website when leaving the site and viewing third party content.
This page was printed directly from www.therutherford.com/crpublications/proton-therapy-in-oncology-clinical-references on 18 Jan 2022, 01:59am and is correct at the time of printing. Please note: this website is updated periodically and information may be amended or deleted if required. Please refer back to the website to ensure the information is correct at the time of enquiry.